Bosh sahifa3692 • HKG
add
Hansoh Pharmaceutical Group Company Ltd
Yopilish kursi
24,10 $
Kunlik diapazon
23,70 $ - 24,60 $
Yillik diapazon
15,32 $ - 25,90 $
Bozor kapitalizatsiyasi
145,71 mlrd HKD
Oʻrtacha hajm
13,56 mln
Narx/foyda
31,24
Dividend daromadliligi
1,37%
Asosiy maydon
HKG
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,88 mlrd | 2,91% |
Joriy xarajat | 1,96 mlrd | 13,40% |
Sof foyda | 823,15 mln | -17,22% |
Sof foyda marjasi | 28,60 | -19,57% |
Har bir ulushga tushum | — | — |
EBITDA | 739,07 mln | -18,16% |
Amaldagi soliq stavkasi | 16,30% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 23,39 mlrd | -6,02% |
Jami aktivlari | 31,66 mlrd | -4,18% |
Jami passivlari | 2,98 mlrd | -58,89% |
Umumiy kapital | 28,68 mlrd | — |
Tarqatilgan aksiyalar | 5,93 mlrd | — |
Narxi/balansdagi bahosi | 4,99 | — |
Aktivlardan daromad | 5,15% | — |
Kapitaldan daromad | 5,67% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 823,15 mln | -17,22% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Tashkil etilgan
1995
Sayt
Xodimlar soni
8 989
